E
GMDA

Ergoteles’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Ergoteles’s Portfolio GMDA Stock Details GMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-74,032
Closed -$95.5K – 1892
2022
Q4 		$95.5K Buy
+74,032
New +$117K ﹤0.01% 1229

Other funds holding GMDA

MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
KHLMVGHM
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return
KHLMTHM
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet Tel Aviv, Israel $506M AUM 21.19% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
YAVAPFMC
Yahav Achim Ve Achayot - Provident Funds Management Company Tel-Aviv, Israel $144M AUM 82.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles's GMDA Position: Q1 2023 in Review

Ergoteles sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q1 2023, closing a stake of 74,032 shares — an estimated $95.5K sold.

Ergoteles first reported a position in GMDA in Q4 2022 and held it in 1 quarter. The position peaked at $95.5K in Q4 2022. 44 funds tracked by Wall St. Rank hold GMDA as of Q1 2023.

  • Ergoteles reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 74,032 Gamida Cell Ltd. Ordinary Shares shares in Q1 2023, an estimated $95.5K.
  • Ergoteles first reported a position in Gamida Cell Ltd. Ordinary Shares in Q4 2022 and held it in 1 quarter.
  • Ergoteles's Gamida Cell Ltd. Ordinary Shares position peaked at $95.5K in Q4 2022.
  • 44 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.